İçeriğe geç
akaturk Akademik ölçüm
  1. Ana Dal Sağlık Bilimleri Temel Alanı
  2. Yan Dal Eczacılık Biyokimyası
Akademik özet YÖKSİS ve OpenAlex ayrı sayılır.
Makale 66
YÖKSİS66 OpenAlex0
Proje 13
Kitap 0
Bildiri 125

Atıf etkisi

OpenAlex YÖKSİS makalelerinden OpenAlex’te eşleşen: 61
h-indeks 21 Türkiye yüzdelik dilimi: 98 Üniversitesinde h-indekse göre 6. / 984
i10-indeks
41
Toplam atıf
1.340
Türkiye’de üst %2,9
Makale başına
22,0
FWCI
2,79
1,00 = dünya ortalaması
Dünyada üst %1
1
Dünyada üst %10
21

h-indeks ve atıflar, bu akademisyenin YÖKSİS makalelerinden OpenAlex’te eşleşenlerin atıf sayılarından hesaplanır (Google Scholar, WoS veya Scopus değildir). Eşleşmeyen makalelerin atıfı dahil değildir.

Alan sıralaması

YÖKSİS ?

Dizin çeyrekleri

?
Scopus (SJR) 63
  • Q1 38 %60,3
  • Q2 16 %25,4
  • Q3 9 %14,3
  • Q4 0 %0,0
WoS (JCR) 62
  • Q1 21 %33,9
  • Q2 24 %38,7
  • Q3 12 %19,4
  • Q4 5 %8,1
TR Index 8 makale
OpenAlex atıf yüzdelik
Üst %11
Üst %1021
Ort. · n 61 %77,3
Diğer sayımlar

Scopus (SJR)

  • YÖKSİS satırı 64

WoS (JCR)

  • YÖKSİS satırı 63

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

66makale

Yayını olan dergiler

37 dergi

Daralt

Scopus (SJR)
Q138 Q216 Q39 Q40
WoS (JCR)
TR Index

Makale listesi

  1. 2026 Design, Synthesis, and Biological Evaluation of N,N-Diphenylaniline-Based Derivatives as Antiproliferative Agents and ABL TK Inhibitors Against CML Pharmaceuticals DOI 10.3390/ph19030416 YÖKSİS TR Index SJR Q3 JCR Q3 OpenAlex üst %1 OpenAlex 99.5%
  2. 2026 Targeting Leukemic Stem Cells: Enhanced Eradication via Tivantinib (ARQ197) and Asciminib (ABL001) with Molecular Docking-Guided Screening of Therapeutic Derivatives JOURNAL OF CHEMOTHERAPY DOI 10.1080/1120009X.2025.2532948 YÖKSİS SJR Q3 JCR Q3 OpenAlex üst %10 OpenAlex 90.8%
  3. 2026 Expression, purification, and crystallization of recombinant human ABL-1 kinase for X-ray crystallography Turkish Journal of Chemistry DOI 10.55730/1300-0527.3776 YÖKSİS TR Index SJR Q3 JCR Q3 OpenAlex üst %10 OpenAlex 91.8%
  4. 2026 Production, Purification, and Initial Crystallization of Recombinant Epidermal Growth Factor Receptor Tyrosine Kinase Domain (EGFR-TKD) as a Structural Basis for Future Drug Screening Studies Türk Tarım ve Doğa Bilimleri Dergisi DOI 10.30910/turkjans.1805082 YÖKSİS TR Index OpenAlex 4.3%
  5. 2025 Structure and Dynamics of the ABL1 Tyrosine Kinase and Its Important Role in Chronic Myeloid Leukemia Archiv der Pharmazie DOI 10.1002/ardp.70005 YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 98.9%
  6. 2025 Design, Synthesis, and Mechanistic Anticancer Evaluation of New Pyrimidine-Tethered Compounds Pharmaceuticals DOI 10.3390/ph18020270 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 99.0%
  7. 2025 Insights into Therapeutic Discovery Through the Kelch Domain Structure of Keap1 at Ambient Temperature Turkish Journal of Biology DOI 10.55730/1300-0152.2742 YÖKSİS TR Index SJR Q2 JCR Q3 OpenAlex 54.0%
  8. 2025 Structural Insights into the Dynamics of Water in SOD1 Catalysis and Drug Interactions International Journal of Molecular Sciences DOI 10.3390/ijms26094228 YÖKSİS SJR Q1 JCR Q1 OpenAlex 54.5%
  9. 2025 Hydrazonylthiazole Derivatives as Dual EGFR and ALR2 Inhibitors: Design, Synthesis, and Comprehensive In Vitro and In Silico Evaluation for Potential Anticancer Activity Pharmaceuticals DOI 10.3390/ph19010050 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 91.5%
  10. 2025 Assessment of the anticancer function of Coronilla orientalis MILLER through comprehensive in vitro and computational studies Turkish Journal of Biochemistry DOI 10.1515/tjb-2024-0251 YÖKSİS SJR Q3 JCR Q4 OpenAlex 8.0%
  11. 2025 A Structural Insight Into Two Important ErbB Receptors (EGFR and HER2) and Their Relevance to Non‐Small Cell Lung Cancer Archiv der Pharmazie DOI 10.1002/ardp.202400992 YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 98.3%
  12. 2025 Design, Synthesis, and Anticancer Evaluation of New Small-Molecule EGFR Inhibitors Targeting NSCLC and Breast Cancer International Journal of Molecular Sciences DOI 10.3390/ijms26157065 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 94.5%
  13. 2024 New naphthalene-linked pyrazoline–thiazole hybrids as prominent antilung and antibreast cancer inhibitors Turkish Journal of Chemistry DOI 10.55730/1300-0527.3704 YÖKSİS TR Index SJR Q3 JCR Q3 OpenAlex üst %10 OpenAlex 91.3%
  14. 2024 Discovery of the Aminated Quinoxalines as Potential Active Molecules Letters in Drug Design & Discovery DOI 10.2174/0115701808281517231215113741 YÖKSİS SJR Q3 JCR Q4 OpenAlex 32.7%
  15. 2024 Scaffold Hopping and Structural Modification of NSC 663284: Discovery of Potent (Non)Halogenated Aminobenzoquinones Biomedicines DOI 10.3390/biomedicines12010050 YÖKSİS SJR Q1 JCR Q1 OpenAlex 51.5%
  16. 2024 A Review of FDA-Approved Anti-HIV-1 Drugs, Anti-Gag Compounds, and Potential Strategies for HIV-1 Eradication International Journal of Molecular Sciences DOI 10.3390/ijms25073659 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 98.9%
  17. 2023 Comparative Study of High-Resolution LysB29(Nε-myristoyl) des(B30) Insulin Structures Display Novel Dynamic Causal Interrelations in Monomeric-Dimeric Motions Crystals DOI 10.3390/cryst13040648 YÖKSİS SJR Q2 JCR Q2 OpenAlex 41.8%
  18. 2023 Evaluation of anti-glioma effects of benzothiazoles as efficient apoptosis inducers and DNA cleaving agents Molecular and Cellular Biochemistry DOI 10.1007/s11010-022-04580-4 YÖKSİS SJR Q1 JCR Q3 OpenAlex 52.9%
  19. 2023 Cryogenic X-ray crystallographic studies of biomacromolecules at Turkish Light Source <i>Turkish DeLight</i> Turkish Journal of Biology DOI 10.55730/1300-0152.2637 YÖKSİS TR Index SJR Q2 JCR Q3
  20. 2023 Turkish Plants, Including Quercetin and Oenothein B, Inhibit the HIV-1 Release and Accelerate Cell Apoptosis Biological and Pharmaceutical Bulletin DOI 10.1248/bpb.b23-00328 YÖKSİS SJR Q2 JCR Q3 OpenAlex 60.7%

← Akademisyenlere dön